Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

Contributed by: Business Wire

Logo

Tags

Technology

Research

Genetics

Health Technology

Biotechnology

Health

Science

Artificial Intelligence

Oncology

Gustave Roussy, precision diagnostics, oncology

More Like This

One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France

Thomas Clozel (CEO of Owkin) joins Emmanuel Macron, Friedrich Merz and others at the Franco-German Digital Sovereignty Summit

Owkin Unveils Europe’s First Pan-European Agentic Infrastructure for Biology at the Franco-German Digital Sovereignty Summit

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies

Parse Biosciences and bit.bio Announce Landmark Alliance

Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides

Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale